QAIS ABUALASSAL

Dr. QAIS ABUALASSAL

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2025 in Molecules
Verified
Journal Article
Open access
PDF file
QAQAIS ABUALASSAL
QAIS ABUALASSAL
ZAZead Helmi Abudayeh
Zead Helmi Abudayeh
ASAla Sirhan
Ala Sirhan
AMAbdul Rahman Mkia
Abdul Rahman Mkia
Quinazoline, a privileged scaffold in medicinal chemistry, offers promising potential in the synthesis of anti-Alzheimer’s disease (AD) drugs. This heterocyclic compound, characterized by its fused benzene and pyrimidine rings, enables the design of multifunctional agents targeting AD pathology. The drug-like aspects and pharmaceutical features of quinazoline derivatives have the potential to give rise to various therapeutic drugs. AD is a progressive neurodegenerative condition marked by memory decline, cognitive deterioration, and language disorders. Given its complexity and multifaceted nature, there is a pressing need to discover multi-target drugs to effectively address this debilitating disorder. A comprehensive literature review has demonstrated that quinazoline derivatives exhibit a wide range of therapeutic potential for AD. These compounds function as inhibitors of cholinesterases, β-amyloid aggregation, oxidative stress, and tau protein, among other protective effects. Here, we highlight the most significant and recent research on quinazoline-based anti-AD agents, aiming to support the development and discovery of novel treatments for AD.

13 October 2022 in Journal of Food Quality
Verified
Journal Article
Open access
PDF file
ZAZead Helmi Abudayeh
Zead Helmi Abudayeh
UKUliana Karpiuk
Uliana Karpiuk
NANarjes Armoon
Narjes Armoon
QAQAIS ABUALASSAL
QAIS ABUALASSAL
EMEyad Mallah
Eyad Mallah
YAYousef Aldalahmeh
Yousef Aldalahmeh
Macroscopic and microscopic analysis of R. damascena buds and flower petals was used to find the main morphological and anatomical features of these types of medicinal plant material (MPM). The presence of polysaccharides, free and bound monosaccharides, tannins, flavonoids, saponins, and essential oils was confirmed by chemical and histochemical reactions. The quality indicator of R. damascena buds and flower petals was evaluated in this study; weight loss on drying gave the next result: 6.690.20 for flower petals and 6.650.13 for buds. The swelling index showed a high result for R. damascena flower petals and buds. R. damascena buds swelling index50.2 and R. damascenaflower petals swelling index150.6. The determination of volatile substances by GC/MS shows the presence of 18 volatile compounds in flower petals and buds, this number varies up to 17. Nonadecane, heneicosane, and octadecane are the main components in both medicinal plant materials. Both buds and flower petals contain approximately the same amount of citronellol. Phenylethyl alcohol is present in large amounts in buds but in small amounts in flower petals. R. damascena flower petals and buds are the sources of volatile compounds, phenols, and polysaccharides. The results of our investigation showed great differences and similarities between buds and flower petals of R. damascena. We have confirmed that not only buds but also flower petals could be a source of biologically active substances (BASs) such as essential oils, polysaccharides, and phenolic compounds. Flower petals could be an alternative MPM. We would also like to underline the importance of standard documentation for MPM: its macro and microscopic description, harvest time, control techniques of the qualitative composition, and the quantitative content of the main BAS. Because it will help in the production of various high-quality products that can be used in medicine, pharmacy, food, and the perfume industries.

29 September 2022 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
ZAZead Helmi Abudayeh
Zead Helmi Abudayeh
UKUliana Karpiuk
Uliana Karpiuk
VKViktoriia Kyslychenko
Viktoriia Kyslychenko
QAQAIS ABUALASSAL
QAIS ABUALASSAL
LHLoay Khaled Hassouneh
Loay Khaled Hassouneh
ATAhmad Talhouni
Ahmad Talhouni
The technological parameters and quality indicators of corn silk were evaluated in this study: specific density, volumetric density, bulk density, porosity, spatial layer, free volume of the layer, the absorption coefficient, weight loss on drying, and extractives. The technology for obtaining a liquid extract of corn silk was developed. The most effective extractant was discovered to be 40% ethanol, with an extraction time of 120 minutes. The qualitative composition and quantitative content of the major groups of biologically active substances (BAS) in the obtained liquid extract were determined. The qualitative composition of the main groups of BAS was determined by conventional chemical reactions. This extract contained free reduced sugars, glycosides (bound reduced sugars), phenols, tannins, flavonoids, saponins, and hydroxycinnamic acids. The quantitative content of phenolic compounds was performed by UV-vis-spectrophotometry. Total phenols, tannins, flavonoids, and hydroxycinnamic acids had quantitative contents of 8.25 ± 0.33%, 1.4 ± 0.03%, 2.20 ± 0.06%, 3.30 ± 0.13%, respectively. The acute toxicity study was carried out with a single intragastric administration to outbred unanesthetized white rats of both sexes. Duration of observation of animals was 14 days. It was revealed that corn silk extract at doses of up to 5.0 ml/kg is safe. A single injection of a liquid extract has no effect on internal organs when compared to a control group. Corn silk liquid extract’s hemostatic efficacy was assessed using blood clotting time, prothrombin time, and blood clot retraction index. The corn silk liquid extract reduces blood coagulation time, decreases prothrombin time, and increases the blood clot retraction index. According to these findings, corn silk liquid extract is rich in phytochemicals and possesses a potential therapeutic effect on bleeding disorders. Furthermore, it could be used in the pharmaceutical sciences industry to develop medicines for testing in the treatment of various diseases.

10 February 2016 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
QAQAIS ABUALASSAL
QAIS ABUALASSAL
Khaldun Mohammad Al AzzamKhaldun Mohammad Al Azzam
Khaldun Mohammad Al Azzam
JJJamal A. Jilani
Jamal A. Jilani

10 December 2020 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Open access
QAQAIS ABUALASSAL
QAIS ABUALASSAL
JJJamal Jilani
Jamal Jilani
AAAreej Assaf
Areej Assaf
RSReham Abu Shmies
Reham Abu Shmies

28 April 2023 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Closed access
LHLoay Hassouneh
Loay Hassouneh
SASalameh Aldajah
Salameh Aldajah
MNManal Najdawi
Manal Najdawi
ZAZead Helmi Abudayeh
Zead Helmi Abudayeh
QAQAIS ABUALASSAL
QAIS ABUALASSAL
ASAla Sirhan
Ala Sirhan